相似文献
1
Lamivudine is not effective in primary Sjögren's syndrome.
Ann Rheum Dis. 2005 Sep;64(9):1326-30. doi: 10.1136/ard.2004.031393. Epub 2005 Feb 11.
2
Prednisone and piroxicam for treatment of primary Sjögren's syndrome.
Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56.
3
Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
Oral Dis. 1997 Jun;3(2):93-8. doi: 10.1111/j.1601-0825.1997.tb00019.x.
4
The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.
BMC Musculoskelet Disord. 2014 Jan 17;15:21. doi: 10.1186/1471-2474-15-21.
5
A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):38-44. doi: 10.1067/moe.2003.30.
6
Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
J Rheumatol. 2002 Feb;29(2):305-8.
7
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
Clin Rheumatol. 2019 Mar;38(3):657-664. doi: 10.1007/s10067-018-4315-8. Epub 2018 Oct 2.
8
[Evaluation of sialometry and minor salivary gland biopsy in classification of Sjögren's Syndrome patients].
Braz J Otorhinolaryngol. 2005 May-Jun;71(3):346-54. doi: 10.1016/S1808-8694(15)31334-3. Epub 2005 Dec 14.
9
Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Arthritis Rheum. 2005 Sep;52(9):2740-50. doi: 10.1002/art.21260.
10
Characterization of Lipids in Saliva, Tears and Minor Salivary Glands of Sjögren's Syndrome Patients Using an HPLC/MS-Based Approach.
Int J Mol Sci. 2021 Aug 20;22(16):8997. doi: 10.3390/ijms22168997.
引用本文的文献
1
Human Endogenous Retroviruses (HERVs) and Autoimmune Rheumatic Disease: Is There a Link?
Open Rheumatol J. 2013 Mar 22;7:13-21. doi: 10.2174/1874312901307010013. Print 2013.
2
Is Sjögren's syndrome a retroviral disease?
Arthritis Res Ther. 2011 Apr 13;13(2):212. doi: 10.1186/ar3262.
本文引用的文献
1
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Arthritis Rheum. 2004 Apr;50(4):1270-6. doi: 10.1002/art.20146.
2
Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
Arthritis Rheum. 2003 Aug 15;49(4):585-93. doi: 10.1002/art.11199.
3
In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Arthritis Rheum. 2003 Aug;48(8):2240-5. doi: 10.1002/art.11103.
4
Pathogenesis of Sjögren's syndrome.
Autoimmun Rev. 2003 Jan;2(1):13-8. doi: 10.1016/s1568-9972(02)00121-0.
5
Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study.
Gerodontology. 2002 Jul;19(1):53-9. doi: 10.1111/j.1741-2358.2002.00053.x.
6
TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjögren's syndrome.
Semin Arthritis Rheum. 2002 Jun;31(6):396-405. doi: 10.1053/sarh.2002.32557.
7
Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Arch Intern Med. 2002 Jun 10;162(11):1293-300. doi: 10.1001/archinte.162.11.1293.
8
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
Ann Rheum Dis. 2002 Jun;61(6):554-8. doi: 10.1136/ard.61.6.554.
9
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Arthritis Rheum. 2002 Mar;46(3):748-54. doi: 10.1002/art.510.
10
Locus DR in primary Sjögren's syndrome.
Bratisl Lek Listy. 2001;102(8):382.
Zotero 插件